How PALADIN Consortium Aims to Enhance Efficient Patient Advocacy-Industry Collaborations

Deirdre BeVard currently serves as SVP, R&D Strategic Operations for CSL. In this role she leads a multi-functional “nerve center” for R&D designed to leverage and connect capabilities across the organization to integrate the business management of R&D; enable data driven insights & decisions; provide operational excellence; enable high performing teams and embed patient focus into the delivery of a diverse and innovative portfolio. Strategic Operations includes Clinical Development Operations, R&D Project & Portfolio Management, Integrated Business Operations, R&D Enabling Technology, R&D Patient Partnerships, and R&D Japan.Previously Ms BeVard has led Clinical Development Operations organizations at Nektar Therapeutics, Endo Pharmaceuticals and Otsuka Pharmaceuticals.  She also held significant leadership roles establishing innovative models dedicated to bringing clinical trials to community physicians and their patients.  Additionally, her background includes working in a CRO and a start-up software company. This diversity of experience has given her a broad and global perspective of the clinical research industry.Ms BeVard strives be a servant leader who operates with humble confidence and a healthy curiosity about people, projects and process. Her leadership expertise is in creating inclusive teams and environments that allow for innovation, performance excellence and personal development.  She has been awarded an HBA Rising Star and PharmaVoice 100 of the Most Inspiring People for Change Agent category.Ms BeVard’s professional passion is in partnering with patients and their providers for increased and optimized opportunities for clinical trials.

Dr Valentino is a Professor of Pediatrics at Rush University Medical Center in Chicago, Illinois USA and is President of the World Federation of Hemophilia USA, which seeks to advance the global mission of the World Federation of Hemophilia in the United States.He also serves as an Entrepreneur in Residence for the National Bleeding Disorders Foundation venture philanthropy program, Pathway to Cures and he is the co-leader of the Paladin Consortium which is dedicated to transforming the pace of medicines development through optimizing patient advocacy group–industry collaboration. Dr Valentino is the editor of Expert Review of Hematology and a regular reviewer for numerous scientific journals include Haemophila, Blood and Journal of Thrombosis and Hemostasis. His research has focused on the molecular mechanisms leading to joint disease in people with hemophilia and he has published extensively in this area. Dr Valentino is a staunch advocate for equitable outcomes in health and wellbeing.